Informations sur le produit
EML 425 is a growth factor that regulates the expression of genes involved in cell signaling and proliferation. EML 425 is categorized as an emergent therapeutic because it has shown clinical efficacy in treating cancer and other diseases. It has been shown to regulate the acetylation of histones, which are proteins that package DNA. The contractile properties of EML 425 have been shown to be useful for treating aneurysms.
EML 425 also has normalizing effects on cells during transition from a healthy state to one that is diseased or transitioning from a proliferative state to a quiescent one.